SENORES PHARMACEUTICALS L (NSE:SENORES) — Market Cap & Net Worth
Market Cap & Net Worth: SENORES PHARMACEUTICALS L (SENORES)
SENORES PHARMACEUTICALS L (NSE:SENORES) has a market capitalization of $655.14 Million (Rs60.58 Billion) as of June 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #11059 globally and #544 in its home market, demonstrating a 18.23% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying SENORES PHARMACEUTICALS L's stock price Rs1315.40 by its total outstanding shares 46053588 (46.05 Million). Review SENORES PHARMACEUTICALS L debt and liabilities to assess the company's total debt and financial obligations.
SENORES PHARMACEUTICALS L Market Cap History: 2025 to 2026
SENORES PHARMACEUTICALS L's market capitalization history from 2025 to 2026. Data shows growth from $409.50 Million to $655.14 Million (0.00% CAGR).
SENORES PHARMACEUTICALS L Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how SENORES PHARMACEUTICALS L's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.11x
SENORES PHARMACEUTICALS L's market cap is 0.11 times its annual revenue
Latest Price to Earnings (P/E) Ratio
59.82x
SENORES PHARMACEUTICALS L's market cap is 59.82 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $409.50 Million | $3.83 Billion | $6.85 Million | 0.11x | 59.82x |
Competitor Companies of SENORES by Market Capitalization
Companies near SENORES PHARMACEUTICALS L in the global market cap rankings as of June 19, 2026.
Key companies related to SENORES PHARMACEUTICALS L by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #14 globally with a market cap of $936.50 Billion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #17 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #27 globally with a market cap of $550.26 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #41 globally with a market cap of $356.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #14 | Eli Lilly and Company | NYSE:LLY | $936.50 Billion | $1098.57 |
| #17 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #27 | Johnson & Johnson | NYSE:JNJ | $550.26 Billion | $228.39 |
| #41 | AbbVie Inc | NYSE:ABBV | $356.49 Billion | $216.49 |
SENORES PHARMACEUTICALS L Historical Marketcap From 2025 to 2026
Between 2025 and today, SENORES PHARMACEUTICALS L's market cap moved from $409.50 Million to $ 655.14 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs655.14 Million | +59.99% |
| 2025 | Rs409.50 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of SENORES PHARMACEUTICALS L was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $655.14 Million USD |
| MoneyControl | $655.14 Million USD |
| MarketWatch | $655.14 Million USD |
| marketcap.company | $655.14 Million USD |
| Reuters | $655.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About SENORES PHARMACEUTICALS L
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, ne… Read more